IUPAC Name: | 1-[(3S)-3-[4-amino-3-[2-(3,5-dimethoxyphenyl)ethynyl]pyrazolo[3,4-d]pyrimidin-1-yl]pyrrolidin-1-yl]prop-2-en-1-one |
Description: | Futibatinib is an orally bioavailable, selective and irreversible inhibitor of fibroblast growth factor receptors (FGFRs), displaying antineoplastic activity. It inhibits FGFR-mediated signal transduction and tumor cell proliferation. |
Molecular Weight: | 418.45 |
Molecular Formula: | C22H22N6O3 |
Canonical SMILES: | COC1=CC(=CC(=C1)C#CC2=NN(C3=C2C(=NC=N3)N)C4CCN(C4)C(=O)C=C)OC |
InChI: | InChI=1S/C22H22N6O3/c1-4-19(29)27-8-7-15(12-27)28-22-20(21(23)24-13-25-22)18(26-28)6-5-14-9-16(30-2)11-17(10-14)31-3/h4,9-11,13,15H,1,7-8,12H2,2-3H3,(H2,23,24,25)/t15-/m0/s1 |
InChI Key: | KEIPNCCJPRMIAX-HNNXBMFYSA-N |
Purity: | ≥ 98 % |
Appearance: | Crystalline solid |
LogP: | 2.30400 |
Customer Support
If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?
Customer Centered
Related Functional Groups
Carbonyl Compounds
(S)-Hexahydropyrazino[2,1-c][1,4]oxazin-4(3H)-one hydrochloride
1-(5-Methoxy-1,3-benzoxazol-2-yl)piperidine-3-carboxylic acid
Customers Also Viewed
N-[2-(4-oxo-4H-3,1-benzoxazin-2-yl)phenyl]-2-naphthalenesulfonamide
Copyright © 2025 BOC Sciences. All rights reserved.
Our Products